Yttrium

An element of the rare earth family of metals. It has the atomic symbol Y, atomic number 39, and atomic weight 88.91. In conjunction with other rare earths, yttrium is used as a phosphor in television receivers and is a component of the yttrium-aluminum garnet (YAG) lasers.

Networked: 746 relevant articles (71 outcomes, 125 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Inorganic Chemicals: 9
- Metals: 21360
  - Rare Earth Metals: 30
    - Yttrium: 746
- Elements: 19226
  - Rare Earth Metals: 30
    - Yttrium: 746
  - Transition Elements: 3
    - Yttrium: 746

Experts

1.	Salem, Riad: 24 articles (01/2022 - 02/2005)
2.	Lewandowski, Robert J: 14 articles (10/2021 - 08/2005)
3.	Gordon, Leo I: 9 articles (09/2007 - 02/2002)
4.	Valandro, Luiz Felipe: 8 articles (02/2024 - 01/2011)
5.	Witzig, Thomas E: 7 articles (07/2013 - 02/2002)
6.	Carr, Brian I: 7 articles (08/2012 - 02/2005)
7.	Emmanouilides, Christos: 7 articles (09/2007 - 02/2002)
8.	Omary, Reed A: 6 articles (03/2014 - 08/2005)
9.	Schilder, Russell J: 6 articles (09/2007 - 01/2004)
10.	Pereira, Gabriel Kalil Rocha: 5 articles (02/2024 - 01/2019)

Related Diseases

1.	Neoplasms (Cancer) 04/01/2024 - "Radioembolization with yttrium 90 (Y-90 TARE) has made significant advancements in treating liver tumors and is now considered a potential option allowing for future resection. " 02/26/2023 - "IC50 values of investigated samples against cancer (HeLa) and normal (MRC-5) cells decreased with increased yttrium concentration and were higher than ~300 μg/mL. The samples of γ-Fe2-xYxO3 did not show a genotoxic effect. " 11/18/2020 - "After the first procedure consisting in cleaning the left hepatic lobe followed by PVE the future liver remnant volume (FLRV) was considered inadequate, so the patient was also treated with right transarterial radioembolizacion with yttrium 90 (TARE-Y90) intending a double goal: to treat the tumor and to increased the FLRV. " 10/01/2019 - "Radioembolization is an IR procedure on the rise that consists of the injection into the hepatic artery of Yttrium 90 loaded microparticles, which will preferentially deliver high dose on the tumors, sparing the adjacent hepatic parenchyma. " 01/01/2015 - "The role of (18)F-FDG positron emission tomography in the follow-up of liver tumors treated with (90)Yttrium radioembolization."
2.	Cicatrix (Scar) 01/01/2014 - "The aim of this study was to investigate the efficacy of the sequential combined 585 nm PDL and the 1064 nm neodymium:yttrium-aluminium-garnet laser (PDL/Nd:YAG) in the treatment of surgical scars and to evaluate the short-term effects by in vivo confocal microscopy (RCM) and the long-term effects by clinical assessment of the scars. " 01/01/2019 - "Currently no study has evaluated the effect of the novel 1064-nm picosecond neodymium-doped:yttrium aluminium garnet laser (ps-Nd:YAG) for reducing Hypertrophic scarring (HS). " 04/01/2012 - "The aim of this study was to assess the efficacy and safety of ablative fractional yttrium-scandium-gallium-garnet (YSGG) laser in patients with residual haemangiomas or with scarring after their surgery. " 10/01/2011 - "Yttrium scandium gallium garnet ablative fractional resurfacing (2,790-nm) appears to be effective and well tolerated for the treatment of atrophic acne scars in Asians. " 01/01/2020 - "To determine the safety and efficacy of fractional ablative erbium-doped yttrium aluminium garnet (Er:YAG) laser in the treatment of hypertrophic burn scars. "
3.	Hepatocellular Carcinoma (Hepatoma) 01/01/2022 - "A global evaluation of advanced dosimetry in transarterial radioembolization of hepatocellular carcinoma with Yttrium-90: the TARGET study." 12/01/2007 - "Other randomized trials are needed in hepatocellular carcinoma, to compare radioembolization with (90)yttrium against transarterial chemoembolization, bland embolization, drug-eluting beads, and best supportive care. " 03/01/2022 - "Transarterial radioembolization (TARE) with yttrium 90 (90Y) has been used in the management of hepatocellular carcinoma (HCC) for more than 10 years in Korea. " 11/01/2021 - "Yttrium 90 Radioembolization for Hepatocellular Carcinoma." 10/01/2021 - "Transarterial radioembolization (TARE) with yttrium 90 has increasingly been performed to treat hepatocellular carcinoma (HCC). "
4.	Non-Hodgkin Lymphoma (Lymphosarcoma) 03/01/2007 - "A 75-year-old man with relapsed follicular non-Hodgkin lymphoma confined to a solitary lung mass was treated with radioimmunotherapy (RIT) using yttrium 90-ibritumomab tiuxetan. " 01/01/2016 - "The aim of the study is to evaluate the therapeutic efficacy and safety of Yttrium- 90 radiolabelled chimeric anti CD20 antibody-Rituximab in the treatment of patients with relapsed/ refractory B cell Non-Hodgkins Lymphoma (NHL). " 04/01/2006 - "Treatment with yttrium 90 ibritumomab tiuxetan at early relapse is safe and effective in patients with previously treated B-cell non-Hodgkin's lymphoma." 10/01/2004 - "Ongoing trials with yttrium 90-labeled ibritumomab tiuxetan in patients with non-Hodgkin's lymphoma." 07/01/2000 - "Dosimetry studies in patients with non-Hodgkin's lymphoma were performed to estimate the radiation absorbed dose to normal organs and bone marrow from 90Y-Zevalin (yttrium-90 ibritumomab tiuxetan, IDEC-Y2B8) treatment in this phase I/II, multicenter trial. "
5.	Smear Layer 02/22/2023 - "Efficacy of Smear Layer Removal at the Apical One-Third of the Root Using Different Protocols of Erbium-Doped Yttrium Aluminium Garnet (Er:YAG) Laser." 09/01/2018 - "The objective of this study was to compare antibacterial and smear layer removal efficacy of the erbium:yttrium-aluminium-garnet (Er:YAG) laser irradiation by photon-induced photoacoustic streaming (PIPS), neodymium:yttrium-aluminium-garnet (Nd:YAG), and diode lasers and conventional irrigation agent in primary molar root canals. " 01/01/2021 - "The purpose was to study the influence of Erbium,Chromium:Yttrium Scandium Gallium Garnet (Er,Cr:YSGG) laser at short pulse duration on smear layer removal from apical root third. " 10/01/2014 - "The purpose of this study was to evaluate the effectiveness of the erbium, chromium: yttrium-scandium-gallium-garnet (Er,Cr:YSGG) laser in removing debris and the smear layer using two different output powers on the apical, middle, and coronal segments of root canal walls. " 08/01/2004 - "This study was performed to investigate the temperature rises on root surfaces and morphological changes on root canal walls of extracted human teeth after irradiation by erbium, chromium: yttrium, scandium, gallium, garnet (Er, Cr:YSGG) laser and to evaluate the efficiency in removing smear layer and debris from the prepared root canal walls in vitro. "

Related Drugs and Biologics

1.	Aluminum
2.	Neodymium
3.	Erbium
4.	Gallium
5.	Scandium
6.	Chromium
7.	Holmium
8.	ibritumomab tiuxetan (Zevalin)
9.	Lutetium
10.	Carbon Dioxide

Related Therapies and Procedures

1.	Solid-State Lasers
2.	Lasers (Laser)
3.	Therapeutics
4.	Microspheres (Microsphere)
5.	Radioimmunotherapy